A detailed history of Entropy Technologies, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Entropy Technologies, LP holds 136,108 shares of BMY stock, worth $7.24 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
136,108
Holding current value
$7.24 Million
% of portfolio
0.61%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$40.25 - $52.99 $5.48 Million - $7.21 Million
136,108 New
136,108 $5.65 Billion
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $567,312 - $676,960
11,702 New
11,702 $600 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Entropy Technologies, LP Portfolio

Follow Entropy Technologies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entropy Technologies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Entropy Technologies, LP with notifications on news.